Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC
Helena A. Yu, Christina S. Baik, D.-W. Kim, Melissa L. Johnson, Hidetoshi Hayashi, Makoto Nishio, James Chih‐Hsin Yang, Wu‐Chou Su, Kathryn A. Gold, Marianna Koczywas, Egbert F. Smit, Conor Steuer, Enriqueta Felip, Haruyasu Murakami, Seung‐Whan Kim, Xin Su, Sho Sato, Pang‐Dian Fan, Mitsunori Fujimura, Yoshimi Tanaka, Parvati B. Patel, David Sternberg, Dalila Sellami, Pasi A. Jänne
Topics & Concepts
MedicineOncologyInternal medicineCancer researchMutationGeneticsGeneBiologyLung Cancer Treatments and MutationsHER2/EGFR in Cancer ResearchLung Cancer Research Studies